Protein-protein interactions are involved in most biological processes and
are important targets for drug design. Over the past decade, there has been
increased interest in the design of small molecules that mimic functional
epitopes of protein inhibitors. BLIP is a 165 amino acid protein that is a
potent inhibitor of TEM-1 beta -lactamase (K-i = 0.1 nM). To aid in the dev
elopment of new inhibitors of beta -lactamase, the gene encoding BLIP was r
andomly fragmented and DNA segments encoding peptides that retain the abili
ty to bind TEM-1 beta -lactamase were isolated using phage display. The sel
ected peptides revealed a common, overlapping region that includes BLIP res
idues C30-D49. Synthesis and binding analysis of the C30-D49 peptide indica
te that this peptide inhibits TEM-1 beta -lactamase. Therefore, a peptide d
erivative of BLIP that has been reduced in size by 88% compared with wild-t
ype BLIP retains the ability to bind and inhibit beta -lactamase.